Cargando…
Pro-haloacetate Nanoparticles for Efficient Cancer Therapy via Pyruvate Dehydrogenase Kinase Modulation
Anticancer agents based on haloacetic acids are developed for inhibition of pyruvate dehydrogenase kinase (PDK), an enzyme responsible for reversing the suppression of mitochondria-dependent apoptosis. Through molecular docking studies mono- and dihaloacetates are identified as potent PDK2 binders a...
Autores principales: | Misra, Santosh K., Ye, Mao, Ostadhossein, Fatemeh, Pan, Dipanjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914936/ https://www.ncbi.nlm.nih.gov/pubmed/27323896 http://dx.doi.org/10.1038/srep28196 |
Ejemplares similares
-
Copper-Catalyzed Syntheses of Pyrene-Pyrazole Pharmacophores
and Structure Activity Studies for Tubulin Polymerization
por: Sar, Dinabandhu, et al.
Publicado: (2018) -
Transcriptional Regulation of Pyruvate Dehydrogenase Kinase
por: Jeong, Ji Yun, et al.
Publicado: (2012) -
Modulation of Muscle Fiber Compositions in Response to Hypoxia via Pyruvate Dehydrogenase Kinase-1
por: Nguyen, Daniel D., et al.
Publicado: (2016) -
The Role of Pyruvate Dehydrogenase Kinase in Diabetes and Obesity
por: Lee, In-Kyu
Publicado: (2014) -
Inhibition of Pyruvate Dehydrogenase Kinase 4 in CD4(+) T Cells Ameliorates Intestinal Inflammation
por: Lee, Hoyul, et al.
Publicado: (2022)